How To Align Medical Marijuana Strains With Specific Conditions: Learn From Dr. Chanda Macias, Scientist, Researcher And Cannabis Pioneer
Dr. Chanda Macias is a trailblazer in the legal cannabis industry many times over.
Read Morgan Stanley’s Take On Shifting Spending Patterns Amid Rising Inflation
Morgan Stanley analysts Kimberley Greenberger, Pam Kaufman, and John Glass saw initial signs of low-income and increasingly middle-income consumer pressure in the first half of FY22.
Now, Morgan Stanley economists have also flagged rising recession risk.
7 Analysts Have This to Say About Colgate-Palmolive
Analysts have provided the following ratings for Colgate-Palmolive (NYSE:CL) within the last quarter:
Short Volatility Alert: Colgate-Palmolive Company
On Wednesday, shares of Colgate-Palmolive Company (NYSE: CL) experienced volatile short activity. After the activity, the stock price went up +0.15% to $78.43.
The overall sentiment for CL has been Bearish.
Looking Into Colgate-Palmolive’s Recent Short Interest
Colgate-Palmolive's (NYSE:CL) short percent of float has fallen 5.03% since its last report. The company recently reported that it has 14.22 million shares sold short, which is 1.7% of all regular shares that are available for trading.
11 Stocks Moved By Traders on ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Golden Cross Appears Before Colgate-Palmolive Investors
If history is any guide, there may be good fortune ahead for shares of Colgate-Palmolive (NYSE:CL). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $71
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $77 to $71.
Barclays Maintains Equal-Weight Rating for Colgate-Palmolive: Here’s What You Need To Know
Barclays has decided to maintain its Equal-Weight rating of Colgate-Palmolive (NYSE:CL) and lower its price target from $81.00 to $77.00.
Shares of Colgate-Palmolive are trading down 0.3% over the last 24 hours, at $74.95 per share.
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $77
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $81 to $77.